Clinicopathological analysis of sinonasal lesions

---

Original Article

Author Details : Medha Kulkarni, Shital Sidhewad, Mansi Thokal*, Alka Gosavi

Volume : 9, Issue : 2, Year : 2022

Article Page : 132-137

https://doi.org/10.18231/j.ijpo.2022.032

Suggest article by email

Get Permission

---

Abstract

Introduction: The sinonasal tract is exposed to a variety of infections, chemical irritants, antigens and trauma giving rise to diverse inflammatory as well as neoplastic lesions.
Aim: The aim was to study the clinicopathological profile of lesions of nose and paranasal sinuses in this area of western Maharashtra.
Materials and Methods: The study included 59 biopsies/resection specimens received in the department during Jan 2015 to June 2019. Clinical and pathological details were analysed.
Results: There were 33 females and 26 males. Out of 59 cases, 46 were nonneoplastic and 13 neoplastic, with 10 benign and three malignant. The most common nonneoplastic lesion was sinonasal polyp (42 cases). Other nonneoplastic lesions included three cases of mucormycosis and one case of rhinosporidiosis. In the benign neoplasms, there were three cases of hemangiomas, two hamartomas, two inverted papillomas with one case each of hidradenoma, angiofibroma and schwannoma. We had three malignant tumors, one case each of, melanoma, poorly differentiated carcinoma and squammous cell carcinoma.
Conclusion: Nonneoplastic lesions were much more common than neoplastic ones in the sinonasal tract. Histopathological examination plays an important role in correct diagnosis and management.
 

Keywords: Sinonasal polyps, Hamartoma, Melanoma.

How to cite : Kulkarni M, Sidhewad S, Thokal M, Gosavi A, Clinicopathological analysis of sinonasal lesions. Indian J Pathol Oncol 2022;9(2):132-137

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.